Latest Risperdal Stories
Pharmaceutical manufacturer, Johnson & Johnson, loses $2.5 million verdict for marketing of Risperdal, a potent antipsychotic that caused female breast growth in a young boy the case revealed.
The Risperdal trial currently underway in the Pennsylvania mass tort, where Bernstein Liebhard LLP is actively filing claims, is the first to involve gynecomastia, and could provide insight into
The Firm is representing numerous gynecomastia plaintiffs who have Risperdal lawsuits pending in the same mass tort litigation.
The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia in the Philadelphia Court of Common Pleas. New York, NY (PRWEB) February
Trial in Philadelphia involves allegations that Janssen Pharmaceuticals and parent company, Johnson & Johnson, failed to warn about the risks of male breast growth, a condition known as gynecomastia,
The Firm is representing numerous gynecomastia plaintiffs in Risperdal lawsuits that are now pending in the same Pennsylvania mass tort litigation. New York,
Johnson & Johnson's bid for a mistrial in a Risperdal case was dismissed by a Pennsylvania state judge, who ruled that the plaintiffs are allowed to bring a new expert to trial after J&J
The Firm is representing numerous Risperdal lawsuit plaintiffs who are also alleged to have developed gynecomastia due to their use of the atypical antipsychotic medication. New
A former U.S.
The Firm is representing numerous Risperdal gynecomastia plaintiffs in the Pennsylvania litigation where this trial is taking place. New York, New York (PRWEB)
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.